股市新闻
最新财经新闻 · 更新于 七月 10, 2026
J&J Phase 1b/2 OrigAMI-4: 皮下注射阿米万替布在头颈癌中显示42%的客观缓解率
J&J Phase 1b/2 OrigAMI-4: Subcutaneous Amivantamab Shows 42% ORR In Head & Neck Cancer
Johnson & Johnson's amivantamab showed promising results with a 42% ORR in heavily pretreated head and neck cancer, but further …
“资金充足” 非政府组织幕后纽瓦克反移民及海关执法局混乱；贝森特暗示将对非营利组织进行打击
"Well-Funded" NGO Machine Behind Newark Anti-ICE Chaos; Bessent Signals Nonprofit Crackdown
The panel discusses potential impacts of IRS guidance on nonprofits tied to activism, with risks including capital flight, reputational damage, …
2 Space Stocks to Buy Before the SpaceX IPO on June 12
The panel consensus is bearish on AST SpaceMobile (ASTS) and Intuitive Machines (LUNR), citing significant execution risks, uncertain revenue visibility, …
用 1,000 美元购买的最佳加密货币
The Best Cryptocurrency to Buy With $1,000 Right Now
The panel is divided on Solana's investment merit, with concerns about repeated outages, unclear ETF timeline, and intense competition from …
Nvidia Recently Plowed $3.8 Billion Into These 2 Artificial Intelligence (AI) Stocks
Despite strategic positioning in AI infrastructure, Nvidia's investments in CoreWeave and Coherent pose significant risks, including high leverage, potential dilution, …
Social Security Work Rules You Must Understand Before Working in Retirement
The panel generally agreed that while working in retirement can potentially increase Social Security benefits, the current system presents significant …
辉瑞公司BRAFTOVI联合疗法在BRAF V600E转移性结直肠癌中几乎使无进展生存期翻倍
Pfizer's BRAFTOVI Combo Nearly Doubles PFS In BRAF V600E Metastatic Colorectal Cancer
Pfizer's BREAKWATER Cohort 3 data shows promising results in first-line BRAF V600E mCRC, with a significant PFS benefit and encouraging …
Eli Lilly 的 Retevmo 3 期 LIBRETTO-432 临床试验在 RET+ 早期非小细胞肺癌中将复发风险降低了 83%。
Eli Lilly's Retevmo Phase 3 LIBRETTO-432 Cuts Recurrence Risk 83% In RET+ Early-Stage NSCLC
Eli Lilly's selpercatinib (Retevmo) showed promising results in a Phase 3 trial, reducing recurrence risk by 83% in early-stage RET-positive …
罕见买入机会可能出现在这支头 phiếu股票中
A Rare Buying Opportunity May Be Here With This Top Stock
Despite strong fundamentals like 75% recurring revenue and 17% procedure growth, the panel is cautious due to high valuation (51x …
SoundHound AI的股票价格在过去6个月下跌了29%——以下是它仍然可能成为长期买入的原因
SoundHound AI's Stock Price Is Down 29% in the Last 6 Months -- Here's Why It Still Could Be a Long-Term Buy
The panel consensus is bearish on SoundHound's planned acquisition of LivePerson, citing immediate dilution, unproven synergies, high integration risk, and …
人工智能硬件瓶颈正在决定下一代万亿美元科技公司
This AI Hardware Bottleneck Is Determining the Next Trillion-Dollar Tech Companies
The panel generally agrees that while AI is driving demand for memory, the cyclical nature of the industry and potential …
英国十分之四的人在出行时难以获得手机信号
Four in 10 struggle to access mobile signal on the move in the UK
The UK's mobile connectivity issues stem from uneven rollout favoring urban areas and congestion in city centers. While government initiatives …